CA9 and renal cell carcinoma: The basic antigen G250 (carbonic anhydrase IX; CAIX) is expressed on the surface of 75% of RCC cells (90% of clear renal cell carcinoma) but has minimal expression in normal cells (121, 122), so that it can become one of the possible therapeutic targets.